Flax seeds: benefits, dosage, contraindications

Mis à jour le

Flax is a plant native to Europe, Asia and the Mediterranean, cultivated for more than 5,000 years for its nutritional and medicinal value. The oil was a traditional food of the Egyptians from the time of the pharaohs to the present day. It is also part of the Chinese pharmacopoeia. It is an annual herbaceous plant that can reach 1 m in height. The blue-colored flowers bloom for only one morning before losing their petals during the day. Flax seeds are ripe 30 days later. The parts used therapeutically are the seed and the seed oil. These seeds contain phytoestrogens, 3-9% mucilaginous polysaccharides and soluble oils. The fiber is found in the seed coat mucilage. The phytoestrogens present in flax seeds include the lignans secoisolariciresinol and matairesinol. Flaxseed oil contains about 55% of alpha-linolenic acid (ALA) (an essential omega-3 fatty acid), making it one of the richest dietary sources of ALA. It also contains other unsaturated fatty acids, such as linoleic acid and oleic acid. Linoleic acid (omega-6) and oleic acid (omega-9) each contribute about 15% to the oil's total fatty acid content. Flax seeds are consumed to relieve constipation and regulate intestinal flora, to help fight cholesterol and hypertension, and more broadly for the prevention of cardiovascular diseases. They can also relieve symptoms of menopause and mastalgia (breast pain). They are also consumed as an emollient preparation for the short-term symptomatic treatment of gastritis and enteritis and for the symptomatic relief of irritable bowel syndrome. They are also used as supportive therapy for the symptoms of diverticulosis. In these three indications, efficacy is based on human experience and long-standing traditional use. Note: although flaxseed and psyllium have the same effects on constipation symptoms, weight, glycemic and lipid levels, treatment with flaxseed appears to be superior to psyllium.

Other name(s) 

Cultivated flax

Scientific name(s)

Linum usitatissimum

Family or group: 

Fatty Acids, Superfood, Plants

Active ingredients:

Alpha-linolenic Acid

Linoleic Acid

Oleic Acid

Secoisolariciresinol Diglucoside (SDG)


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Constipation
✪✪✪✪✪

Flaxseed is an important source of dietary fiber and has a laxative effect. In a clinical trial in healthy young adults, muffins containing 25 g of ground flaxseed, consumed twice daily for 4 weeks, increased weekly bowel movements by 30% compared with a control group. Other clinical research in diabetic patients with constipation shows that taking 10 g of flaxseed twice daily for 12 weeks improves stool form and moderately reduces constipation compared with placebo.

Posologie

posologieOral: seed

posologie15 - 50 g

formulationpowder, seeds


Hypercholesterolemia
✪✪✪✪✪

Most research shows that daily intake of 20 to 50 g of flaxseed reduces total cholesterol by 5 to 15% and LDL cholesterol by 8 to 18% in various populations, including those with normal cholesterol levels, patients with hypercholesterolemia, postmenopausal women, and patients with or at risk for cardiovascular disease. Although some studies have shown that flaxseed preparations do not affect triglyceride levels, a large meta-analysis — when analyzing subgroups — shows that flaxseed consumption does indeed reduce triglyceride levels in overweight or obese patients, or those with high baseline triglyceride levels.

Posologie

posologieOral: seed

posologie20 - 50 g

formulationpowder, seeds


High blood pressure
✪✪✪✪✪

Meta-analyses of clinical research show that flaxseed is effective in reducing blood pressure; however, the magnitude, dose, and most effective form remain to be determined. According to a subgroup analysis, consumption of ground flaxseed was effective in reducing both diastolic and systolic blood pressure, flaxseed oil was effective in reducing only diastolic blood pressure, while flaxseed lignan extract showed no effect on hypertension.

Posologie

posologieOral: seed

posologie30 - 60 g

formulationpowder, seeds


Type 2 diabetes
✪✪✪✪✪

Flaxseed may improve blood glucose control in patients with type 2 diabetes. Effects appear to be greater with consumption of whole flaxseeds, in those who have higher baseline blood glucose and insulin levels, and when used for at least 12 weeks. Patients receiving flaxseed oil also demonstrated improvements in markers of insulin metabolism and inflammation. A meta-analysis of 25 clinical trials involving 1,879 patients shows that whole flaxseed can reduce blood glucose compared with control treatments such as wheat germ or uncooked rice. Another recent meta-analysis of 7 clinical trials shows that taking flaxseeds, typically ground, at doses of 13 to 40 g per day for 8 to 12 weeks has a modest beneficial effect on fasting blood glucose, insulin, insulin resistance, and glycated hemoglobin (HbA1c), compared with no intervention or using another source of fiber. Other studies have shown that using a standardized flax lignan extract 600 mg three times daily, providing 360 mg of secoisolariciresinol diglucoside (SDG), reduces HbA1c in patients with type 2 diabetes, but does not appear to improve fasting blood glucose, insulin levels, or insulin resistance in patients with type 2 diabetes. Furthermore, there is a beneficial effect of flax seeds in preventing diabetes complications. Indeed, a high dietary intake of ALA has been associated with a lower risk of peripheral neuropathy.

Posologie

posologieBy mouth: seed

posologie10 - 60 g

formulationpowder, SDG-standardized extract, oil, seeds


Mastalgia
✪✪✪✪✪

Clinical research shows that taking 25 g of flaxseed powder per day for 2 months reduces breast pain intensity by approximately 72% and pain duration by 60% compared with baseline in healthy women suffering from cyclic mastalgia; compared with placebo.

Posologie

posologieOral: seed

posologie25 g

formulationpowder


Obesity
✪✪✪✪✪

Supplementation with flaxseed, but not with lignan extract or flaxseed oil, appears to be modestly beneficial for obese or overweight patients. nnIndividual clinical studies and a meta-analysis of 45 trials involving 2,561 patients show that consumption of flaxseed reduces body weight, body mass index (BMI), and waist circumference. nnAccording to a meta-analysis, body weight is reduced by an average of 1.75 kg, BMI by an average of 0.63 kg/m2, and waist circumference by an average of 1.21 cm compared with control in adults, most of whom were overweight or obese at baseline. The greatest benefit is observed in adults with a baseline BMI greater than or equal to 27. Consumption of at least 30 g of flaxseed per day for at least 12 weeks demonstrated the greatest effectiveness. nnFlax lignan extract and flaxseed oil do not appear to be effective for reducing weight, BMI, or waist circumference.nn

Posologie

posologieOral: seed

posologie30 g

duration12 - weeks

formulationseeds


Cardiovascular diseases
✪✪✪✪✪

Epidemiological evidence for the prevention of secondary coronary events due to ALA, in the context of a modified Mediterranean diet, supports the hypothesis of prevention or treatment of cardiovascular disease. In secondary prevention trials, such as the Lyon Diet Heart Study (1999), which reports the effects of the Mediterranean diet, ALA has been shown to have a significant cardioprotective effect, with a reduction in the risk of recurrent myocardial infarction, fatal and non-fatal, and a significant 73% reduction in the risk of major cardiac mortality and morbidity endpoints. Researchers suggest that the omega-3 component ALA in the oil contributes to the anti-atherogenic effect through anti-inflammatory and antiproliferative mechanisms. They suggest that dietary flaxseed may also protect against ischemic heart disease by improving vascular relaxation responses and by inhibiting the incidence of ventricular fibrillation.

Posologie

posologieOrally: seed

posologie2 - 5 g

formulationoil


Prostate cancer
✪✪✪✪✪

Preliminary clinical research suggests that flaxseed may affect the prostate and prostate cancer markers. The addition of ground flaxseed at a dose of 30 g per day, combined with a low-fat diet, reduces prostate-specific antigen (PSA) levels in men with prostatic intraepithelial neoplasia (PIN), a precancerous proliferation of prostatic epithelial cells. It also appears to slow the proliferation of the prostatic epithelium. Population studies also suggest that dietary lignan intake is associated with a decreased risk of developing prostate cancer. Flaxseed is one of the most important sources of lignans. However, no research has specifically evaluated the effect of flaxseed consumption on prostate cancer risk.

Posologie

posologieOral: seed

posologie30 g

formulationpowder


Breast cancer
✪✪✪✪✪

Large population studies suggest that a high intake of dietary lignans is associated with a significant reduction in the risk of developing breast cancer. One population study suggests that lignan intake is associated with a reduced risk of breast cancer in premenopausal women, but not in postmenopausal women. Consuming 25 g of ground flaxseed per day for about 40 days markedly reduces markers of tumor cell proliferation in women who have been recently diagnosed with breast cancer. However, the effect of flaxseed consumption on breast cancer outcomes is unknown.

Posologie

posologieOral: seed

posologie25 g

duration40 - days

formulationpowder


Chronic inflammatory bowel diseases
✪✪✪✪✪

Preliminary clinical research conducted on patients with ulcerative colitis shows that taking 30 g of ground flaxseed per day for 12 weeks reduces disease severity and improves quality of life compared with control. Preliminary clinical research conducted on patients with ulcerative colitis shows that taking 10 g of flaxseed oil per day for 12 weeks improves disease symptoms and quality of life compared with control.

Posologie

posologieOral: seed

posologie30 g

duration12 - weeks

formulationpowder, oil


Menopause
✪✪✪✪✪

The evidence regarding the effect of flaxseed on menopausal symptoms has been contradictory. Some randomized clinical trials have reported significant reductions in hot flashes after 12 weeks of treatment. Other studies conclude that flaxseed was not found to be effective in reducing the severity or frequency of hot flashes. Biomarkers of estrogenic effects (endometrial thickness or vaginal epithelium) did not change during these trials.

Posologie

posologieOral: seed

posologie25 g

formulationpowder


Benign prostatic hyperplasia (BPH)
✪✪✪✪✪

Preliminary clinical research shows that taking a flaxseed lignan extract, at a dose of 300 mg or 600 mg per day for 4 months, significantly reduces lower urinary tract symptom scores as well as quality-of-life scores, compared with placebo, in men suffering from benign prostatic hyperplasia. These results remain to be confirmed.

Posologie

posologieOral: seed

posologie1 - 2 g

formulationExtract standardized in SDG


Digestive disorders
✪✪✪✪✪

Mucilage appeared to have a palliative effect in patients suffering from pain associated with gastrointestinal problems. In an open pilot study, 70 patients with various functional disorders of the upper abdomen, such as sensations of pressure and fullness, loss of appetite, nausea, vomiting and cardiac disturbances, were treated with an aqueous preparation of flaxseed mucilage (1:10) at a dose of 8 x 25 g per day. All patients except three experienced improvements. After three days, the total symptom score had decreased significantly. The score for each individual symptom decreased on average, with the largest reductions observed for the sensation of pressure (41.5%) and the sensation of fullness (36.8%). In global evaluations, by both patients and physicians, efficacy was judged good or very good in most cases.

Posologie

posologieOral: seed

posologie5 - 10 g

formulationSeeds


Irritable bowel syndrome
✪✪✪✪

Flax seeds are most frequently used for irritable bowel syndrome but also for inflammation of the intestine caused by excessive laxative use. At this stage there is no scientific evidence to support these traditional uses.

Posologie

posologieOral: seed

posologie24 g

formulationpowder


Dermatoses
✪✪✪✪

Supportive treatment for symptoms of painful skin inflammation. Efficacy is plausible based on human experience and long-standing use.

Posologie

posologieOral: seed

posologie30 - 50 g

formulationpoultice


Properties


Cardiovascular

full-leaffull-leaffull-leafempty-leaf

Flax seeds are used for atherosclerosis because they can reduce platelet aggregation and serum cholesterol and could thus decrease atherogenic risks. Flax seeds also contain alpha-linolenic acid (ALA), which may help reduce serum cholesterol. Because ALA can be converted into long-chain polyunsaturated fatty acids (omega-3) in humans, it could potentially reproduce the beneficial effects of fish oils. It has been shown that ALA has a significant cardioprotective effect, with a reduction in the risk of recurrent myocardial infarction, both fatal and nonfatal, and a significant reduction in the risk of major measures of cardiac mortality and morbidity. It has been suggested that alpha-linolenic acid (ALA) in flaxseed oil contributes to the anti-atherogenic effect via anti-inflammatory and antiproliferative mechanisms.

Usages associés

Cardiovascular diseases

Digestive effect

full-leaffull-leaffull-leafempty-leaf

Mucilage may have a palliative effect in patients suffering from pain associated with gastrointestinal problems. In an open pilot study, 70 patients suffering from various functional disorders of the upper abdomen, such as sensations of pressure and fullness, loss of appetite, nausea, vomiting and cardiac disturbances, were treated with an aqueous preparation of flaxseed mucilage (1:10) at a dose of 8 x 25 g per day. All patients except three experienced improvements. After three days, the total symptom score had decreased markedly. The score for each individual symptom decreased on average, with the largest reductions observed for the feeling of pressure (41.5%) and the feeling of fullness (36.8%). In overall assessments, by both patients and physicians, efficacy was judged to be good or very good in most cases.

Usages associés

Irritable bowel syndrome, Digestive disorders

Anticancer

full-leaffull-leafempty-leafempty-leaf

Secoisolariciresinol and matairesinol are metabolized by intestinal bacteria of mammalian gut flora into enterolignans, respectively enterodiol and enterolactone. Because of their structure related to that of estradiol, enterolignans act as selective estrogen receptor modulators. They are referred to as SERMs (specific estrogen receptor modulators).nnDepending on the nature of the phytoestrogen (PE), and on the ratio of PE/estrogen concentrations, enterolignans can then act:nn- as agonists, by mimicking the binding of estrogens, but with different effects depending on subsequent interaction with activators or inhibitors of transcription of certain genes.nn- as antagonists, by preventing estrogen binding and thus inhibiting its receptor-mediated action.nnThey can therefore inhibit the proliferative effect of estrogen-dependent breast cancer cells by competitively reducing the binding of endogenous estrogens to estrogen receptors, which would result in an anti-estrogen effect.nnIn a systematic review [Flower 2014] including 2 randomized controlled trials, 2 uncontrolled trials, one biomarker study and 5 observational studies, flaxseed (25 g/day) increased the tumor apoptotic index and decreased HER2 expression and cell proliferation in women recently diagnosed with breast cancer compared with placebo. nnThe uncontrolled and biomarker studies suggested beneficial effects on cell proliferation, atypical cytomorphology and mammographic density, as well as potential antiangiogenic activity at doses of 25 g of ground flaxseed or 50 mg of secoisolariciresinol diglucoside (SDG) per day. nnTurning to prostate cancer, clinical research shows that flaxseed (30 g/day) can affect the prostate by reducing prostate cancer markers, such as prostate-specific antigen (PSA) levels, and by slowing the proliferation of the prostate epithelium. nnAlthough the mechanism of action is not clear, in men, urinary enterolignan levels are correlated with a reduction in prostate cancer cell proliferation, suggesting a possible role for enterolignans derived from flax lignans.nn

Usages associés

Prostate cancer, Breast cancer, Benign prostatic hyperplasia

Laxative

full-leaffull-leafempty-leafempty-leaf

Dietary fibers such as flax seeds bind to water and swell to form a demulsifying gel in the intestine. Because the water bound to these fibers cannot be absorbed in the colon, the stools are softened and the volume of intestinal contents increases. A decrease in transit time and an increase in stool weight due to physical stimulation of intestinal peristalsis with flax seeds were demonstrated in two multicenter studies (n=108 and n=114) in patients suffering from constipation.

Usages associés

Constipation

Estrogenic action

full-leaffull-leafempty-leafempty-leaf

Lignans are phytoestrogens with weak estrogenic and possibly anti-estrogenic effects. Serum concentrations and urinary excretion of lignans can increase to varying degrees when people consume large amounts of flaxseed and other lignan-containing foods. Lignans share certain structural similarities with endogenous estrogens; each has a diphenolic cyclic structure. Flaxseed lignans alter estrogen metabolism to produce less active estrogen metabolites. In an open, randomized, crossover study involving 18 women with normal cycles, the effects of ingesting flaxseed powder on the menstrual cycle were examined. Each subject consumed her usual omnivorous, low-fiber diet (control) for 3 cycles and her usual diet supplemented with flaxseed (10 g/day) for 3 additional cycles. During the 36 control cycles, 3 anovulatory cycles occurred, compared with none during the 36 flaxseed cycles. Compared with ovulatory control cycles, the ovulatory flaxseed cycles were consistently associated with longer luteal phase (LP) lengths (mean 12.6 vs. 11.4 days). There were no significant differences between the flaxseed cycles and the control cycles with respect to estradiol or estrone concentrations during the early follicular phase, mid-follicular phase, or the LP. Although flaxseed ingestion did not have a significant effect on luteal phase progesterone concentrations, luteal phase progesterone/estradiol ratios were significantly higher during the flaxseed cycles. Mid-follicular phase testosterone concentrations were slightly higher during the flaxseed cycles. Flaxseed ingestion had no effect on DHEA-S, PRL, or SHBG concentrations at the beginning of the follicular phase.

Usages associés

Menopause, Mastalgia

Hypolipidemic

full-leaffull-leafempty-leafempty-leaf

Flaxseed, at a daily dose ranging from 20 to 50 g, can significantly reduce total cholesterol (TC) and LDL-C. The cholesterol-lowering effects were more apparent in women (particularly postmenopausal women) and in individuals with a high baseline cholesterol level. No significant change was observed in HDL-C and triglyceride concentrations. Whole flaxseed is the most commonly studied form in lipid-reduction studies, because the high fiber content and ALA were thought to act synergistically, which is why there are relatively few studies using oil alone. Those conducted with the oil have produced conflicting results. At worst, the oil caused an increase in fasting triacylglycerol concentrations and a decrease in HDL cholesterol. At best, it has been described in earlier studies as having effects comparable to bioequivalent doses of fish oils.

Usages associés

Hypercholesterolemia

Anti-inflammatory

full-leafempty-leafempty-leafempty-leaf

ALA (in flaxseed oil) suppresses AA production by interfering with the conversion of LA to AA (arachidonic acid), and reduces the biosynthesis of inflammatory eicosanoids, though not to the same extent as EPA and DHA. Cytokines, another important group of inflammatory mediators, are generated in response to these eicosanoids and are influenced by changes in the omega-3/omega-6 ratios in cell membranes. In one study, consumption of flaxseed oil (equivalent to 13.7 g/day of ALA) for 4 weeks by healthy male subjects resulted in a 30% reduction in TNF-alpha, a 31% reduction in IL-1-beta, a 29% reduction in thromboxane B(2), and a 30% reduction in PGE2. Also, a number of studies have confirmed that high-dose flaxseed oil consumption reduces endothelial inflammation. Flaxseed has been shown to improve inflammatory markers, including C-reactive protein and interleukin (IL)-6, as well as certain adhesion markers. The anti-inflammatory effects of flaxseed may help protect against cardiovascular disease and other metabolic diseases.

Usages associés

Vascular disorders, Irritable bowel syndrome

Antihypertensive

full-leafempty-leafempty-leafempty-leaf

A meta-analysis of 15 trials with 1,302 participants after supplementation with various flaxseed-based products showed significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP). The reduction in SBP was significant with flaxseed powder but not with the oil or the lignan extract. However, DBP was significantly reduced with powder and oil preparations but not with the lignan extract.

Usages associés

Hypertension

Vascular effect

full-leafempty-leafempty-leafempty-leaf

In a 12-week study conducted on healthy subjects aged 55 to 75 years, low levels of ALA (equivalent to about 5 ml/day of flaxseed oil) were shown to decrease certain markers of endothelial activation. Specifically, ALA reduced plasma concentrations of soluble VCAM-1 by 16% and soluble E-selectin by 23%.

Usages associés

Cardiovascular diseases, Vascular disorders

Hypoglycemic

full-leafempty-leafempty-leafempty-leaf

Viscous dietary fibers can delay gastric emptying, as shown by some studies on non–insulin-dependent diabetic volunteers. The addition of certain types of dietary fiber to the diet significantly reduced postprandial hyperglycemia. The postprandial glycemic response to a 50 g carbohydrate load given in the form of flaxseed bread is 27% lower than that of ordinary white bread. Flaxseed also appears to lower insulin levels in postmenopausal women and to reduce insulin levels and blood glucose in adults.

Usages associés

Type 2 diabetes


Safe dosage

Adults 12 years and older: 5 g - 60 g (powder)

- As a laxative: 5 g of whole seeds, finely cracked or freshly crushed, soaked in water and taken with a glass of liquid three times a day. The effect begins 18 to 24 hours later.  - Supportive treatment for dyslipidemia and hypertension: 20 to 50 g per day. - As an emollient for gastritis and/or enteritis: for a mucilaginous preparation, soak 5–10 g of whole flax seeds in 150 ml of water and strain after 20–30 minutes - Topical use: 30–50 g of crushed or powdered seeds (may be defatted) as a poultice or hot compress Because of the gradual mode of action of laxatives, treatment should be continued for at least 2 to 3 days to ensure optimal benefit. Flax seeds (whole, finely cracked, or freshly ground) should be soaked and taken with additional liquid, otherwise lumping and intestinal obstruction can occur. For example: 15 g of crushed or ground flax seeds to be taken in several doses. The last dose should be taken around 4:00 PM. Soak the seeds beforehand in a large volume of water (150 ml) for about twenty minutes, swallow everything, and drink one or two additional glasses of water.

Adults 12 years and older: 2 g - 5 g (oil)

- Anticoagulation: 5.9 g/day of ALA. - Improvement of endothelial function: 2 g/day of ALA - Lipid balance: 60 ml/day of flaxseed oil. - Prevention of coronary heart disease: 1-3 g/day ALA. Product quality is a key element of flaxseed oil supplementation. Due to the high potential for oil oxidation, it is recommended to use only refrigerated oils packaged in opaque containers. Once opened, the product should be consumed within a few weeks of opening and stored in the refrigerator.

Children 6 to 12 years:

Half of the adult dose.


Interactions

Médicaments

Antiplatelet agents/Anticoagulants: low interaction

Flaxseed oil can decrease platelet aggregation. Caution with concurrent use of aspirin, clopidogrel, dalteparin, enoxaparin, heparin, ticlopidine, warfarin...

Antidiabetic agents: low interaction

It is important to closely monitor blood glucose levels when antidiabetic medications and flaxseed are taken simultaneously.


Precautions

Children up to 6 years: use with caution

Use under medical supervision

Pregnant women: avoid

There is a lack of sufficient data. In line with general medical practice, the product should not be used during pregnancy without medical advice.

Breastfeeding women: avoid

There is not enough data.

Bleeding disorders: avoid

There is evidence that the oil in flaxseed can decrease platelet aggregation. In theory, flaxseed could increase the risk of bleeding in patients with bleeding disorders; use with caution.


Contraindications

Intestinal obstruction: contraindicated

People with an intestinal obstruction, esophageal narrowing, or acute intestinal inflammation should avoid consuming large amounts of flaxseed. The risk is reduced if flaxseed is consumed with an adequate amount of liquid.